Filipe Almeida

Filipe studied the influence of the biomechanics of the tumor microenvironment at The Wistar Institute in Philadelphia, and most recently developed composite biomaterials for the delivery of anticancer drugs at NOVA University of Lisbon. Previously, at Queen Mary University of London, where he obtained his PhD in 2015, where he studied how skin cells respond to their microenvironment by using advanced microfabricated biomaterials, and developed micropatterned surfaces for high-content imaging and drug screening. Filipe’s interests span mechanobiology, biomechanics, cellular imaging, tissue engineering, nanotheranostics and cancer therapies. Filipe joined Nature Biomedical Engineering in November 2021 and he is based in Berlin.